Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Pfizer's lung cancer combination therapy approved by the FDA
08:41am, Thursday, 12'th Oct 2023
Pfizer Inc (NYSE:PFE) announced that the United States Food and Drug Administration (FDA) has approved BRAFTOVI (encorafenib) plus MEKTOVI (binimetinib) for adult patients with metastatic non-small
FDA approves Pfizer's Braftovi plus Mektovi for a type of non-small cell lung cancer
06:56am, Thursday, 12'th Oct 2023
Pfizer Inc. PFE, -0.18% said Thursday the U.S. Food and Drug Administration has approved its Braftovi plus Mektovi combination therapy as a treatment for patients with metastatic non-small cell lung c
FDA finds no misconduct at trial sites for Pfizer's Lyme disease shot- Care Access
01:21pm, Wednesday, 11'th Oct 2023
The U.S. health regulator did not find any misconduct at clinical sites managed by Care Access for Pfizer and French partner Valneva's trial of a Lyme disease vaccine candidate, the contract research
Cancer Biotechs Pique Buyout Interest: Recent Deals in Focus
12:47pm, Tuesday, 10'th Oct 2023
The M&A trend of 2023 shows that there is an increasing interest in biotech companies making innovative cancer treatments.
BEAM Focuses on Developing Gene Drug for Growth
11:16am, Tuesday, 10'th Oct 2023
While BEAM's pipeline candidates are in early-stage clinical studies, their development is progressing well. Collaborations are a primary source of revenues in the absence of a marketed product.
Dividend Alert: Buy Pfizer Stock Before This Date!
07:52am, Tuesday, 10'th Oct 2023
In 2023, a year when the market has heavily favored technology stocks, drugmakers like Pfizer (NYSE: PFE ) seem to have been left behind. However, if PFE stock is trading at a low price and Pfizer rew
Pfizer (PFE) Rises Yet Lags Behind Market: Some Facts Worth Knowing
06:47pm, Monday, 09'th Oct 2023
Pfizer (PFE) concluded the recent trading session at $33.20, signifying a +0.21% move from its prior day's close.
Final Trades: PFE, HYG, ZM & DAL
06:24pm, Monday, 09'th Oct 2023
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
7 Dividend Stocks Ready to Roar Into 2024
10:06am, Monday, 09'th Oct 2023
In the ever-evolving financial realm, dividend stocks to buy continue to hold a revered space in a savvy investor's portfolio. These dividend-yielding stalwarts offer a steady income source, along wit
5 Ideal Fortune 500 Top October Dividend Dogs
09:43am, Sunday, 08'th Oct 2023
The Summer 2023 edition of Fortune Magazine revealed 500 biggest U.S. companies by revenue. The latest quest to sniff-out the best dividend buys focused on 68 industry leaders using YCharts 10/5/23 da
5 Relatively Safe And Cheap Dividend Stocks To Invest In - October 2023
09:30am, Saturday, 07'th Oct 2023
This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering large discounts to their historical norms. We go over our filtering pr
Novavax's updated Covid vaccine can still catch up to Pfizer, Moderna shots this fall
08:00am, Saturday, 07'th Oct 2023
Novavax's Covid shot is arriving nearly three weeks after new jabs from Pfizer and Moderna reached Americans — but analysts aren't worried about that delay.
Better Growth Stock: Novo Nordisk vs. Pfizer
09:45am, Friday, 06'th Oct 2023
Pfizer has been actively acquiring companies as it looks to bolster its future growth prospects. Novo Nordisk's top weight-loss drug has more than quadrupled sales and there's more growth ahead.
Nobel for mRNA: Which other biotech stocks might be overlooked?
08:33am, Friday, 06'th Oct 2023
Scientists Katalin Karikó and Drew Weissman were awarded the Nobel prize this week for a discovery that went under the radar for many years, until it was found to hold the key to stabilising mRNA v
2 High-Yield Dividend Stocks to Buy in October
11:00am, Wednesday, 04'th Oct 2023
High-yield dividend stocks can significantly boost a portfolio's performance over time. Pfizer and AT&T are two attractively priced dividend stocks with well above average yields.
